RAMM Pharma Corp. (CSE: RAMM)

Market Cap	2.39M
Revenue (ttm)	4.59M
Net Income (ttm)	-8.92M
Shares Out	119.39M
EPS (ttm)	-0.07
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.0200
Previous Close	0.0200
Day's Range	0.0200 - 0.0200
52-Week Range	0.0150 - 0.1000
Beta	-0.27
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 27, 2024

About RAMM Pharma

RAMM Pharma Corp. engages in the research and development, production, and sale of cannabinoid pharmacology and formulations, pharmaceuticals, cosmetics, and nutraceutical products in Uruguay, Italy, and Poland. The company also engages in the resale of medical supplies products; and sale of medical devices and consumables, and veterinarian products. It offers Cosmetic CBD+CBG. The company was formerly known as MTC Growth Fund-I Inc. and changed its name to RAMM Pharma Corp. in October 2019. RAMM Pharma Corp. was incorporated in 1987 and is bas...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1987
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: RAMM

Financial Performance

In 2023, RAMM Pharma's revenue was 5.07 million, an increase of 29.96% compared to the previous year's 3.90 million. Losses were -7.72 million, -63.16% less than in 2022.